End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
840.2 INR | +2.10% | +2.15% | +27.87% |
05-15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
04-25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.87% | 1.24B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- GLS Stock
- News Glenmark Life Sciences Limited
- Transcript : Glenmark Life Sciences Limited, Q4 2023 Earnings Call, Apr 28, 2023